insights_auto
Why is SCNI down 2.22%?
Dive Deeperchevron_right
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
$0.44
arrow_downward
-2.22%(-0.0100) 1D
$0.43
arrow_downward
-2.27% (-0.010)bedtimeAfter hours
Closed: Nov 6, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SCNI...
Open
$0.45
High
$0.49
Low
$0.43
Mkt. cap
1.34M
Avg. vol.
2.32M
Volume
13.13K
52-wk high
$13.00
52-wk low
$0.39
EPS
-$2.80
Beta
2.27
Shares outstanding
706.59K
No. of employees
45
Open
$0.45
High
$0.49
Low
$0.43
Mkt. cap
1.34M
Avg. vol.
2.32M
Volume
13.13K
52-wk high
$13.00
52-wk low
$0.39
EPS
-$2.80
Beta
2.27
Shares outstanding
706.59K
No. of employees
45
News stories
From web sources and news partners
BigGo Finance
·
33 minutes ago
Nasdaq Slides Into Correction as Fear Gauge Hits 'Extreme Fear'; Buffett's Crisis Playbook Back in Focus
24/7 Wall St.
·
15 minutes ago
Bitcoin's Correlation With the S&P 500 Just Hit 0.80. Is Bitcoin Trading Like a Tech Stock Again?
Binance
·
20 minutes ago
TradFi News | Nasdaq Drops 3.4% in Week as AI Chip Stocks Slump; Berkshire Posts Record $9.6 Billion Buyback
Yahoo Finance
·
4 hours ago
Coca-Cola (KO) Makes the Dow’s Low-Upside List While Selling More Drinks, Not Just Charging More
Profile
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases.
In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR
CEO-
Employees45
FoundedJan 1, 2003
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitescinai.com